Lee Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-68
| Closed | -$59.7K | – | 661 |
|
|
2023
Q4 | $59.7K | Buy |
68
+6
| +10% | +$5.27K | 0.01% | 215 |
|
|
2023
Q3 | $51K | Hold |
62
| – | – | 0.01% | 216 |
|
|
2023
Q2 | $44.6K | Hold |
62
| – | – | 0.01% | 231 |
|
|
2023
Q1 | $50.9K | Hold |
62
| – | – | 0.01% | 228 |
|
|
2022
Q4 | $44.7K | Hold |
62
| – | – | 0.01% | 261 |
|
|
2022
Q3 | $42K | Buy |
62
+1
| +2% | +$677 | 0.01% | 264 |
|
|
2022
Q2 | $36K | Sell |
61
-2
| -3% | -$1.18K | 0.01% | 270 |
|
|
2022
Q1 | $44K | Buy |
63
+41
| +186% | +$28.6K | 0.01% | 250 |
|
|
2021
Q4 | $14K | Hold |
22
| – | – | ﹤0.01% | 432 |
|
|
2021
Q3 | $13K | Hold |
22
| – | – | ﹤0.01% | 397 |
|
|
2021
Q2 | $12K | Hold |
22
| – | – | ﹤0.01% | 384 |
|
|
2021
Q1 | $10K | Hold |
22
| – | – | ﹤0.01% | 387 |
|
|
2020
Q4 | $11K | Hold |
22
| – | – | ﹤0.01% | 367 |
|
|
2020
Q3 | $12K | Hold |
22
| – | – | ﹤0.01% | 380 |
|
|
2020
Q2 | $14K | Hold |
22
| – | – | ﹤0.01% | 321 |
|
|
2020
Q1 | $11K | Hold |
22
| – | – | ﹤0.01% | 287 |
|
|
2019
Q4 | $8K | Hold |
22
| – | – | ﹤0.01% | 383 |
|
|
2019
Q3 | $6K | Hold |
22
| – | – | ﹤0.01% | 411 |
|
|
2019
Q2 | $7K | Buy |
+22
| New | +$7K | ﹤0.01% | 408 |
|